Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis.

ABSTRACT: Human coronavirus OC43 (HCoV-OC43) is predominantly associated with mild respiratory infections. HCoV-OC43 also has neuroinvasive properties, and severe encephalitis has been described in immunocompromised patients, with fatal outcomes due to the lack of specific antiviral treatment. We report a case of severe febrile encephalitis attributed to HCoV-OC43 that progressively worsened over 3 months in a 65-year-old immunocompromised man. Clinical symptoms improved remarkably after treatment with remdesivir, with an increase of the Glasgow Coma Score from 8 to 14 within 7 days.

SUBMITTER: Fourgeaud J 

PROVIDER: S-EPMC11923506 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature